ContraFect Announces Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

NEXT STORY
Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
PREV STORY
Latin America Cell Analysis Market Analysis and Forecast, 2019-2025: Offering of High-Content Screening Services by Contract Research Organizations (CROs)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn Pharmaceuticals Presents Preliminary Efficacy Data from the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Bladder Cancer at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting

RX-3117 Monotherapy Increased Progression Free Survival and Showed Evidence of Tumor Shrinkage in Patients ...

author_avatar
NASDAQ Market News

G1 Therapeutics Reports Second Quarter 2017 Financial Results and Recent Operational Highlights

Completed enrollment of Phase 2a small-cell lung cancer trial, with topline data expected in ...

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Top-line Data from Fixed Dose Portion of Phase 2 Trial Demonstrating Potential of TransCon™ PTH as a Replacement Therapy for Hypoparathyroidism

author_avatar
NASDAQ Market News